Boston Children's Hospital oversees the largest and most active research effort at any pediatric center in the world. Our Brain Center is home to hundreds of clinical experts and laboratory researchers, all working together to quickly apply scientific discoveries to new treatment approaches for children. This means we offer many therapies, including clinical trials, that might not be available elsewhere.
Genetics researcher Alan Beggs, PhD, and his team are exploring how genes influence neuromuscular disorders. They hope to use this knowledge to develop new diagnostics and therapies.
Clinical trials are studies that may involve:
evaluating the effectiveness of a new drug therapy
testing a new diagnostic procedure or device
examining a new treatment method for a particular disease
taking a closer look at the causes and progression of specific conditions
If your physician recommends that your child participate in a clinical trial, you can feel confident that the plan detailed for that study represents the best and most innovative care. Taking part in a clinical trial at Children’s is entirely voluntary. Our team will be sure to fully address any questions you may have, and you may remove your child from the medical study at any time.
Search current and upcoming clinical trials at Children’s.
Infant seizure trial
Bumetanide clinical trial shows promise for treating infant seizures
Laboratory discoveries by a Boston Children’s neurologist that detail the physiology and biochemistry of a baby's brain have recently explained why most infants seem immune to anticonvulsants. This finding has led Janet Soul, MD, director of Children’s Fetal-Neonatal Neurology Program, to develop new treatments specific to infant biology, including a pilot study of bumetanide to treat newborns experiencing early seizures.
Read more about the evolution of this clinical trial.